Abstract
It was the task of the present HTA to evaluate, within the PEK context, the efficacy, appropriateness (in terms of demand and safety) and economy of homeopathy. For this purpose the situation in Switzerland had to be assessed and reflected as realistically as possible.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alderson P, Green S, Higgins J. Cochrane Reviewers’ Handbook. Handbook 4.2.1. [updated December 2003]. Chichester: John Wiley & Sons Ltd, 2004
Altman DG, Bland JM. Absence of evidence is not evidence of absence. British Medical Journal 1995;311:485
Chaufferin G. Improving the evaluation of homeopathy: economic considerations and impact on health. British Homeopathic Journal 2000;89(1):27–30
Cucherat M, Haugh MC, Gooch M, Boissel JP. Evidence of clinical efficacy of homeopathy (A meta-analysis of clinical trials). European Journal of Clinical Pharmacology 2000;56:27–33
Glanville J, Sowden A. Identification of the need for a review. In: Khan K, ter Riet G, Glanville J, Sowden A, Kleijnen J (editors). Undertaking Systematic Reviews of Research on Effectiveness. CRD Report Number 4 (2nd Edition), York, 2001
Güthlin C, Walach H. Prospektive Dokumentationsstudie in der niedergelassenen Praxis – ein Erprobungsverfahren zur Akupunktur und Homöopathie. Erfahrungsheilkunde 2001;(50):186–94
Güthlin C, Lange O, Walach H. Measuring the effects of acupuncture and homeopathy in general practice: An uncontrolled prospective documentation approach. BMC Public Health 2004;4(6).
Heusser P. Komplementärmedizin in der Grundversicherung: Verteuert sie die Gesundheitskosten? Schweizerische Zeitschrift für GanzheitsMedizin 1999;11 :4–9
Jenny S, Simon M, Meier B. Haltung der Bevölkerung gegenüber der Komplementärmedizin Schweizerische Zeitschrift für GanzheitsMedizin 2002;14:340–7
Kienle G. Arzneimittelsicherheit und Gesellschaft. Eine kritische Untersuchung. Stuttgart New York: Schattauer, 1974
Kienle GS, Kiene H. Können aus der Studie „Komplementärmedizin in der Krankenversicherung“ wissenschaftlich tragfähige Schlüsse gezogen werden? Forschende Komplementärmedizin 1999;6(5):262–70
Kienle GS, Kiene H, Albonico HU. Anthroposophic Medicine. Effectiveness, utility, costs, safety. Stuttgart New York: Schattauer 2006b
Kleijnen J, Knipschild P, ter Riet G. Clinical trials of homeopathy. British Medical Journal 1991;302(6772):316–23.
Linde K, Clausius N, Ramirez G, Melchart D, Eitel F, Hedges LV, Jonas WB. Are the clinical effects of homeopathy placebo effects? A meta-analysis of placebo-controlled trials. Lancet 1997;350(9081):834–43.
Linde K, Melchart D: Randomized controlled trials of individual homeopathy: a state-of-the-art review. The Journal of Alternative and Complementary Medicine 1998;4(4):371–388
Lüdtke R, Rutten ALB. The conclusions on the effectiveness of homeopathy highly depend on the set of analyzed trials. Journal of Clinical Epidemiology. 2008; 61 (12):1197–1204.
Marstedt G, Moebus S. Gesundheitsberichterstattung des Bundes Heft 9: Inanspruchnahme alternativer Methoden in der Medizin. Berlin: Verlag Robert Koch Institut, 2002
Mathie RT: The research ecidence base for homeopathy: a fresh assessment of the literature. Homeopathy 2003; 92(2):84–91
Niroomand F. Evidenzbasierte Medizin: Das Individuum bleibt auf der Strecke. Deutsches Ärzteblatt 2004; 101(26):1870–4
Rutten AL, Stolper, CF. The 2005 meta-analysis of homeopathy: the importance of post-publication data. Homeopathy. 2008;97(4):169–77
Schüppel R. Kosten und Nutzen der Homöopathie - Ein echtes Schnäppchen? Der Hausarzt 2003;19:64
Shang A, Huwiler-Muntener K, Nartey L et al. Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy. Lancet 2005; 366:726–732
SIGN 50 (Scottish Intercollegiate Guidelines Network). A guideline developer‘s handbook. Notes on the use of Methodology Checklist 2: Randomized Controlled Trials. 2005. available at: http://www.sign.ac.uk/guidelines/fulltext/50/notes2.html
Sommer JH, Burgi M, Theiss R. Inclusion of complementary medicine increases health costs. Focus on Alternative & Complementary Therapies 1999;4(4):183–4
Taieb C, Myon E. The economic impact of homeopathic management: the french example. Value Health 2003; 6(3):373
Trichard M, Chaufferin G, Nicoloyannis N. Pharmacoeconomic comparison between two drug stragegies of treatment of anxiety disorders: homeopathy and psychotropics (ISPOR Poster PMH23). Value in Health 2003; 6(3):350–1
Walach H. Unspezifische Therapie-Effekte – Das Beispiel Homöopathie. Habilitationsschrift Psychologisches Institut, Albert-Ludwigs-Universität Freiburg, 1997
Wegscheider K. Was sind faire Vergleiche zwischen Therapien? Zeitschrift für ärztliche Fortbildung und Qualität im Gesundheitswesen 2005;99(4–5):275–8
Wein C. Qualitätsaspekte klinischer Studien zur Homöopathie. Essen: KVC-Verlag, 2002
World Medical Association, Declaration of Helsinki. Ethical principles for medical research involving human subjects. Bulletin of the World Health Organization, 2001;79(4):373–4. available at: http://whqlibdoc.who.int/bulletin/2001/issue4/79(4)declaration.pdf
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Bornhöft, G., v. Ammon, K., Righetti, M., Thuneysen, A., Matthiessen, P.F. (2011). Full discussion of the HTA results. In: Bornhöft, G., Matthiessen, P.F. (eds) Homeopathy in Healthcare – Effectiveness, Appropriateness, Safety, Costs. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-20638-2_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-20638-2_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-20637-5
Online ISBN: 978-3-642-20638-2
eBook Packages: MedicineMedicine (R0)